Hedge funds made big changes at drug companies in Q2: Reuters
For many prominent hedge fund managers who bet Pfizer Inc and Allergan Plc would merge to become the world's biggest pharmaceuticals company, the second quarter started with a thud that sent many in search of new opportunities, Reuters reported. As investors mulled alternatives, even embattled Canadian drug maker Valeant Pharmaceutical International Inc's name emerged as a possible winner amid the wreckage.
15 August 2016•3 mins read
